Severe Eosinophilic Asthma

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Research Summary
woman taking pills
Research Summary
Azithromycin Reduces Residual Exacerbations in Biologic-Treated Severe Asthma: A Single-Center Audit
09/23/2025
Anthony Calabro, MA
In patients with severe asthma who experience persistent exacerbations despite biologic therapy, azithromycin reduced both steroid- and antibiotic-requiring events and improved symptom control, according to...
09/23/2025
Review
doctor and patient
Review
Allergic Asthma Therapy and Management
06/10/2024
Carlos A. Arango, MD; Daniel A. Reich, MD
Allergic asthma comprises up to 90% of asthmatic cases in the pediatric population. Among this population, studies have shown that as much as one in every two patients experience inadequate control of their...
06/10/2024
Research Summary
man coughing
Research Summary
Established Treatment For Severe Eosinophilic Asthma Shows Clinical Efficacy For Patients With Asthma, COPD
11/16/2022
Treatment with interleukin-5/interleukin-5 receptor antibodies is clinically effective in patients with severe eosinophilic asthma and COPD.
11/16/2022

Interactive Features

Pop Quiz
Pop Quiz
Assessing Symptom Improvement with Azithromycin in Severe Asthma
04/21/2015
Anthony Calabro, MA
Azithromycin may offer added benefit for patients with severe asthma who continue to experience exacerbations despite biologic therapy. Which outcome best reflects its impact on asthma control in this...
04/21/2015

Clinical Insights

EXpert Q&A
EXpert Q&A
Best Practices for Managing Severe Asthma
04/19/2022
Sandhya Khurana, MD, from the University of Rochester, answers our questions about evidence-based best practices when addressing the special needs of patients with severe asthma.
04/19/2022